Central nervous system metastases are believed to be becoming more clinically evident as long-term survival for epithelial ovarian cancer (EOC) and primary peritoneal cancer (PPC) has improved. Our objective was to report our experience with managing brain metastatic disease (BMD) in patients with EOC and PPC.
Department of Obstetrics, Gynecology and the Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520-8063, USA. elena.ratner@yale.edu